Updates are available Correction dated 2022-11-10

Article History

Received: 5 October 2022

Accepted: 13 October 2022

First Online: 24 October 2022

Change Date: 10 November 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s43678-022-00408-8

Declarations

:

: Dr. Newman-Toker conducts research related to diagnosis of dizziness and stroke, as well as diagnostic error. He serves as the principal investigator for multiple grants and contracts on these topics, including the NIH-sponsored AVERT clinical trial (NIDCD U01 DC013778, ClinicalTrials.gov #NCT02483429). Johns Hopkins has been loaned research equipment (video-oculography [VOG] systems) by two companies for use in Dr. Newman-Toker’s research; one of these companies has also provided funding for research on diagnostic algorithm development related to dizziness, inner ear diseases, and stroke. Dr. Newman-Toker has no other financial interest in these or any other companies. Dr. Newman-Toker is an inventor on a provisional patent (US No. 62/883,373) for smartphone-based stroke diagnosis in patients with dizziness. He gives frequent academic lectures on these topics and occasionally serves as a medico-legal consultant for both plaintiff and defense in cases related to dizziness, stroke, and diagnostic error. Dr. Jeffrey Perry receives funding from a peer-reviewed Mid-Career Salary Support Award from the Heart and Stroke Foundation of Ontario.

Free to read: This content has been made available to all.